<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">Safety is the primary consideration of any vaccine development program, given the anticipated administration to large numbers of people. Beyond the expected reactogenicity profiles, studies with other distantly and closely related coronaviruses have raised concerns that humoral vaccine responses might potentiate SARS-CoV-2 infection via immune enhancement mechanisms. Immune enhancement might occur via at least two distinct mechanisms, detailed below.</p>
